These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 1283763)
21. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Hodge AM; Dowse GK; Zimmet PZ Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026 [TBL] [Abstract][Full Text] [Related]
22. Insulin resistance: trigger or concomitant factor in the metabolic syndrome. Avogaro A Panminerva Med; 2006 Mar; 48(1):3-12. PubMed ID: 16633326 [TBL] [Abstract][Full Text] [Related]
23. Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Nisoli E; Clementi E; Carruba MO; Moncada S Circ Res; 2007 Mar; 100(6):795-806. PubMed ID: 17395885 [TBL] [Abstract][Full Text] [Related]
24. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Cersosimo E; DeFronzo RA Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274 [TBL] [Abstract][Full Text] [Related]
29. Impairment of glucose tolerance: mechanism of action and impact on the cardiovascular system. Beck-Nielsen H; Hother Nielsen O; Damsbo P; Vaag A; Handberg A; Henriksen JE Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):292-5. PubMed ID: 2115296 [TBL] [Abstract][Full Text] [Related]
30. Is Insulin Resistance a Feature of or a Primary Risk Factor for Cardiovascular Disease? Laakso M Curr Diab Rep; 2015 Dec; 15(12):105. PubMed ID: 26458376 [TBL] [Abstract][Full Text] [Related]
34. Glucocorticoids and insulin resistance: old hormones, new targets. Andrews RC; Walker BR Clin Sci (Lond); 1999 May; 96(5):513-23. PubMed ID: 10209084 [TBL] [Abstract][Full Text] [Related]
35. Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective. Conte M; Franceschi C; Sandri M; Salvioli S Trends Endocrinol Metab; 2016 Dec; 27(12):893-903. PubMed ID: 27659144 [TBL] [Abstract][Full Text] [Related]
36. [Background of cardiovascular diseases in adult--with special reference to metabolic disorder of glucose and hypertension]. Iimura O Nihon Ronen Igakkai Zasshi; 1994 Jan; 31(1):1-9. PubMed ID: 8158864 [No Abstract] [Full Text] [Related]
37. Scaffold Proteins: From Coordinating Signaling Pathways to Metabolic Regulation. Mugabo Y; Lim GE Endocrinology; 2018 Nov; 159(11):3615-3630. PubMed ID: 30204866 [TBL] [Abstract][Full Text] [Related]
39. States of insulin resistance: the interaction between hypertension, glucose intolerance, and coronary heart disease. Proceedings of a symposium. Montreal, Canada, June 24, 1990. Am Heart J; 1991 Apr; 121(4 Pt 2):1267-318. PubMed ID: 1672574 [No Abstract] [Full Text] [Related]
40. Molecular Aspects of Cardiometabolic Diseases: From Etiopathogenesis to Potential Therapeutic Targets. Bernatova I; Bartekova M Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892029 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]